Barbara Maglione’s journey into the executive corridors of Farmaceutici Damor did not begin with a grand plan or an early ambition to lead. It started in the world of research and development, a space defined by data integrity, scientific rigor, and a relentless pursuit of clinical truth. She spent her early years deeply immersed in the science, analyzing evidence, ensuring accuracy, and contributing to research that had the potential to improve patient outcomes. But with time, she recognized something essential: science alone, no matter how strong, remains still unless paired with clear strategy and powerful leadership. This realization shaped her transition into an executive role. She saw herself as the bridge-the person who could connect scientific excellence with actionable business strategy, ensuring that every breakthrough at Damor reached the patients it was designed to help.
“Leadership is not about having every answer; it is about creating a system where people feel safe enough to tell you the truth.”
Her entry into leadership coincided with the formation of a team that would eventually become one of Damor’s strongest assets. The team did not come together through a formal program or careful planning. Instead, it emerged naturally in response to an incredibly complex regulatory and commercial launch that required a rare level of cross-functional collaboration. Scientists, analysts, strategists, and regulatory experts found themselves working side-by-side, solving problems that demanded both precision and flexibility. Their shared vision-to develop pharmaceutical solutions that truly improve quality of life while upholding absolute scientific integrity-grew organically. As Barbara recalls, the team quickly realized that their success depended entirely on their ability to function as a unified force. Every challenge they faced reinforced one truth: they would succeed or fail as one entity.
What makes this team stand apart is something Barbara describes as “productive impatience”-a refusal to accept inefficient methods or outdated practices simply because they have always existed. Her team is a careful blend of skeptical thinkers and bold innovators. They question assumptions, break down unnecessary processes, and challenge each other constantly, not out of competition, but out of shared ambition. They combine deep scientific knowledge with strong business insight, making them capable of reshaping systems rather than simply operating within them. This culture of constructive friction, as Barbara calls it, keeps them sharp and continuously evolving.
To maintain such high-functioning teamwork, Barbara invests heavily in building trust-trust grounded in complete transparency. She does not protect her team from tough data, shifting market conditions, or uncomfortable truths. She expects honesty, clarity, and responsibility in return. Under her leadership, collaboration is not optional or a box to check; it is an essential part of daily operations. Damor follows a “no silos” approach, where every person is encouraged to cross departmental boundaries whenever necessary. For Barbara, if a problem involves more than one area, then collaboration becomes the responsibility of the person who identifies the issue. Her constant message is simple: if you need help, it is your job to seek it.
This culture is supported by a strong set of core values that define Damor’s operational identity. Scientific integrity stands at the top-data truth above everything else. Every member of the team understands that their work carries a responsibility that goes far beyond the company; it directly influences patient well-being. Total accountability is another non-negotiable value. Barbara believes in removing the temptation to assign blame. Instead, the focus is always on finding solutions. Execution matters just as much as ideas, and the team is trained to move decisively from theory to action. And finally, respect for time-clear communication, efficient meetings, and staying focused on what truly matters-shapes the rhythm of their workflow.
Talent within Damor is identified not by volume or visibility, but by curiosity and insight. Barbara looks for people who ask questions that reveal deep thinking, people who are more interested in challenging assumptions than making noise. Once she identifies talent, she nurtures it through real autonomy. Rather than providing generic training sessions, she assigns high-stakes problems and equips individuals with the resources needed to solve them. She believes failure should never be treated as a final verdict but as a form of feedback that strengthens future performance. This approach has created a team that is confident, resilient, and continuously improving.
“We don’t succeed as individuals-we succeed or fail as one entity, driven by shared purpose and absolute integrity.”
One of the biggest tests Barbara and her team faced was an unexpected supply chain disruption during a crucial product ramp-up phase. The challenge threatened timelines, market commitments, and operational stability. Instead of reacting with panic or blame, they set up a “war room”-a focused environment where quick decisions and cross-functional teamwork were essential. Micro-teams were formed to handle sourcing, manufacturing adjustments, and regulatory communication. The success of the mission depended on discipline, speed, and allowing experts to make decisions without waiting for prolonged approval cycles. What emerged from the crisis was not just a solved problem, but a strong example of how trust, communication, and decentralization can turn a major threat into a defining victory.
In terms of motivation, Barbara believes in meaningful recognition rather than superficial rewards. When someone achieves something exceptional, she makes sure the acknowledgment is specific and public. Her team receives direct rewards such as significant bonuses or dedicated time off, but more importantly, they experience the satisfaction of seeing their work reflected in real-world patient outcomes. This connection between effort and impact, she believes, is the strongest motivator anyone could ask for.
Communication within Damor is structured but open. Barbara follows an asymmetrical approach-she shares top-level information transparently and expects her team to ask questions, challenge interpretations, and request clarity whenever needed. Weekly briefings provide updates on the business without any filters. Her open-door policy is more than symbolic; team members regularly bring her unresolved problems and early warnings, trusting that transparency will be met with support. After every major project, the team holds a post-mortem-an honest discussion focused not on mistakes but on lessons and improvements.
For Barbara, leadership also means balancing individual strengths with the unified direction of the company. She believes that strengths should define ownership of tasks, while the direction itself must remain aligned with the overarching mission and regulatory requirements. Each person has the freedom to express their expertise, but within the boundaries that ensure compliance and consistency. A strategist may drive creative direction, but a regulatory expert defines what is possible. This harmony between individuality and unity allows the team to move with both creativity and discipline.
Creativity is actively encouraged, especially in the form of controlled experimentation. Barbara dedicates a section of the budget to low-risk experiments-projects that may fail but could also unlock tremendous benefits. She invites her team to present bold, unconventional ideas supported by scientific or financial logic. Her responsibility then becomes shielding these ideas from unnecessary bureaucracy so that innovation can flourish without fear.
Teamwork remains central to every major objective at Damor. Whether it’s launching a new drug, expanding into a new market, or achieving a compliance milestone, progress depends on cross-functional alignment. Barbara often says that Damor cannot operate like a relay race; the departments cannot simply pass the baton and hope for the best. Instead, they must run together, ensuring continuity, clarity, and shared responsibility. Without strong teamwork, even the most promising scientific work would remain theoretical and unrealized.
“The best science is meaningless unless we build the strategy and leadership to bring it to the patients who need it.”
Differences of opinion, in Barbara’s view, are not signs of dysfunction but indicators of passion. When conflicts arise, she relies on data and structured debate. The team begins by defining the shared goal. Each side then presents evidence supporting their proposal. If results are inconclusive, the team designs a small test, allowing data-not hierarchy-to determine the best path forward. This approach removes ego from the discussion and reinforces a culture where truth matters more than titles.
At the heart of everything lies Damor’s mission and vision. Barbara ensures alignment by consistently connecting every project and decision back to the “why.” Whether it is a market expansion plan or a new clinical study, the final reminder always focuses on the patient and the company’s integrity. For Barbara, the mission is not a slogan to be referenced occasionally; it is a guiding principle woven into everyday communication and documentation.
Through her years of experience, Barbara has come to understand that leadership is not about having every answer. It is about asking the right questions, creating an environment where people feel safe to share the truth, and trusting the expertise of the individuals around her. She sees her role as a facilitator, a protector of integrity, and a builder of systems that allow others to excel.
Looking ahead to 2025, Barbara and her team have two key aspirations. The first is strategic market penetration-successfully introducing Damor’s new therapeutic agent into three major European markets while demonstrating clear clinical advantage. The second is achieving unmatched operational excellence by improving supply chain efficiency and reducing lead times by 15 percent without affecting quality. These goals reflect the team’s drive to pair scientific progress with commercial success, ensuring that more patients gain access to the treatments they need.
In every part of her journey, Barbara Maglione stands as a leader who combines science with strategy, intellect with empathy, and ambition with authenticity. Her work at Farmaceutici Damor reflects a commitment not only to the company’s growth but to the people, processes, and principles that make true progress possible.
